SCHEMBL10558334

SCHEMBL10558334

COc1ccc(C(=O)Nc2nc3cc4c(cc3[nH]2)NC(=O)C4(C)C)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.58
NPC1 O15118 6/20 0.58
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
PKM P14618 2/20 0.58
ESR1 P03372 1/20 0.53
SMN1; SMN2 Q16637 5/20 0.53
LMNA P02545 2/20 0.53
MAPT P10636 2/20 0.53
IRAK4 Q9NWZ3 1/20 0.48
CSNK1E P49674 2/20 0.48
CSNK1G3 Q9Y6M4 1/20 0.48
GSK3B P49841 4/20 0.47
TP53 P04637 1/20 0.45
KLF5 Q13887 1/20 0.45
TUBB4A P04350 1/20 0.43
TUBB P07437 1/20 0.43
TUBA3C P0DPH7 1/20 0.43
TUBA1B P68363 1/20 0.43
TUBA4A P68366 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9834995 0.86 PDE4A (0.55) RAB9ANPC1MEN1KMT2APKM
SCHEMBL10557685 0.83 KDM4E (0.49) MEN1KMT2AMAPTGSK3B
SCHEMBL9379065 0.81 RAB9A (0.55) RAB9ANPC1MEN1KMT2APKM
SCHEMBL9834410 0.81 PDE4A (0.46) RAB9ANPC1MEN1KMT2APKM
SCHEMBL9834452 0.80 AURKA (0.49) SMN1; SMN2LMNAIRAK4TUBB4ATUBB
SCHEMBL9835322 0.77 PDE4A (0.45) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL10478082 0.76 KMT2A (0.59) RAB9ANPC1MEN1KMT2APKM
SCHEMBL9375666 0.76 NPC1 (0.59) RAB9ANPC1MEN1KMT2APKM
SCHEMBL9833536 0.75 NPC1 (0.45) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL16766582 0.75 CSNK1E (0.80) RAB9ANPC1MEN1KMT2APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4863945-A CARDIOVASCULAR DISORDERS BOEHRINGER MANNHEIM GMBH (DE) 1989-09-05 US disclosed
EP-0271040-A2 Pyrrolobenzimidazoles, process for their preparation, and medicaments Roche Diagnostics GmbH (DE) 1988-06-15 EP disclosed